Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10330)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2022 (publication date) through Nov 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Nagase N, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy. World J Diabetes 2022; 13(3): 150-160 [PMID: 35432750 DOI: 10.4239/wjd.v13.i3.150] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Nagase N, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy. World J Diabetes 2022; 13(3): 150-160 [PMID: 35432750 DOI: 10.4239/wjd.v13.i3.150] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i3/150.htm |
| Number | Citing Articles |
| 1 |
Farideh Ghavidel, Hamed Amiri, Masoud Homayouni Tabrizi, Soodeh Alidadi, Hossein Hosseini, Amirhossein Sahebkar. The Combinational Effect of Inulin and Resveratrol on the Oxidative Stress and Inflammation Level in a Rat Model of Diabetic Nephropathy. Current Developments in Nutrition 2024; 8(1): 102059 doi: 10.1016/j.cdnut.2023.102059
|
| 2 |
Pradipta Paul, Ridhima Kaul, Ali Chaari. Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials. International Journal of Molecular Sciences 2022; 23(23): 14838 doi: 10.3390/ijms232314838
|
| 3 |
Elmukhtar Habas, Amnna Rayani, Aml Habas, Kalifa Farfar, Eshrak Habas, Khaled Alarbi, Ala Habas, Elmehdi Errayes, Gamal Alfitori. Advances in understanding and managing diabetic kidney disease: An updated review. Ukrainian Journal of Nephrology and Dialysis 2025; (1(85)): 66 doi: 10.31450/ukrjnd.1(85).2025.09
|
| 4 |
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda. Advantageous tactics with certain probiotics for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantation. World Journal of Hematology 2023; 10(2): 15-24 doi: 10.5315/wjh.v10.i2.15
|
| 5 |
Xia-Qing Wu, Lei Zhao, Yan-Long Zhao, Xin-Yao He, Liang Zou, Ying-Yong Zhao, Xia Li. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota. Pharmaceutical Biology 2024; 62(1): 423 doi: 10.1080/13880209.2024.2351946
|
| 6 |
Ruijun Zhou, Wenbin Wen, Xiaoli Gong, Yanxia Zhao, Wei Zhang. Nephro‐protective effect of Daphnetin in hyperoxaluria‐induced rat renal injury via alterations of the gut microbiota. Journal of Food Biochemistry 2022; 46(12) doi: 10.1111/jfbc.14377
|
| 7 |
Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda. Promising Tactics with Certain Probiotics for the Treatment of Nephropathy in Hematopoietic Stem Cell Transplantation. OBM Transplantation 2022; 6(03): 1 doi: 10.21926/obm.transplant.2203165
|
| 8 |
Yang Yang, Bing Zhao, Yuanzhe Wang, Hongli Lan, Xinyu Liu, Yue Hu, Peng Cao. Diabetic neuropathy: cutting-edge research and future directions. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02175-1
|
| 9 |
Yongjie Xu, Changyudong Huang, Yiqiong Zhang, Haizhi Li, Huiru Yang, Mi Liu, Liying Zhu, Chengcheng Li, Yinxue Zhong, Lei Tang, Shuyun Zhao, Wei Pan. Diabetic encephalopathy models: A systematic review from cells to animals. Experimental Neurology 2026; 395: 115477 doi: 10.1016/j.expneurol.2025.115477
|
| 10 |
Xiaofang Wu, Lei Zhao, Yujiang Zhang, Kailong Li, Jurong Yang. The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1166685
|
| 11 |
Wei Yan, Ying Ge, Lina Wang, Yuntao Wang, Daikun He. Causal relationship of gut microbiota with diabetic nephropathy: a Mendelian randomization analysis. Frontiers in Microbiology 2024; 14 doi: 10.3389/fmicb.2023.1281361
|
| 12 |
Moeka Nakashima. Comprehension of gut microbiota and microRNAs may contribute to the development of innovative treatment tactics against metabolic disorders and psychiatric disorders. International Journal of Physiology, Pathophysiology and Pharmacology 2024; 16(6): 111 doi: 10.62347/WAZH2090
|
| 13 |
Guoquan Xu, Haisheng Yuan, Jingran Liu, Xianjue Wang, Li Ma, Yuzhen Wang, Guicheng Dong. Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota. International Journal of Molecular Sciences 2025; 26(4): 1470 doi: 10.3390/ijms26041470
|
| 14 |
Naoko Suga, Yuka Ikeda, Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Satoru Matsuda. In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases. Neurology International 2023; 15(3): 967 doi: 10.3390/neurolint15030062
|
| 15 |
Xiao-Jun Li, Qi-Yuan Shan, Xin Wu, Hua Miao, Ying-Yong Zhao. Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05532-5
|
| 16 |
Rui Lin, Rongping Chen. Exploring the causal connection: insights into diabetic nephropathy and gut microbiota from whole-genome sequencing databases. Renal Failure 2024; 46(2) doi: 10.1080/0886022X.2024.2385065
|
| 17 |
Weiguo Yao, Jinlin Huo, Kun liu, Pengyu Tao. Exploring the beneficial effect of gut microbiota metabolites on diabetic nephropathy via network pharmacology study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-95824-y
|
| 18 |
Yi-Wei Kuo, Yen-Yu Huang, Shin-Yu Tsai, Jiu-Yao Wang, Jia-Hung Lin, Zun-Jie Syu, Hui-Shan Wang, Yu-Chieh Hsu, Jui-Fen Chen, Ko-Chiang Hsia, Hsieh-Hsun Ho. Probiotic Formula Ameliorates Renal Dysfunction Indicators, Glycemic Levels, and Blood Pressure in a Diabetic Nephropathy Mouse Model. Nutrients 2023; 15(12): 2803 doi: 10.3390/nu15122803
|
| 19 |
Banani Bhattacharjee, Arnob Chakrovorty, Maharaj Biswas, Asmita Samadder, Sisir Nandi. To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds. Current Medicinal Chemistry 2024; 31(24): 3752 doi: 10.2174/0929867330666230519112312
|
| 20 |
Peipei Wang, Ruixue Guo, Xiwen Bai, Wen Cui, Yiding Zhang, Huangmin Li, Jin Shang, Zhanzheng Zhao. Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1034818
|
| 21 |
Fei Huang, Jing Wei. Knockdown of UHRF1 ameliorates high glucose-induced podocyte injury by activating SIRT4. Molecular & Cellular Toxicology 2024; 20(3): 591 doi: 10.1007/s13273-023-00371-0
|
| 22 |
Xiaoran Wang, Xinyin Liu, Fanghong Gong, Yan Jiang, Canwei Zhang, Wei Zhou, Wen Zhang. Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1621968
|